Intensity-Modulated Radiotherapy as Primary Therapy for Prostate Cancer: Report on Acute Toxicity After Dose Escalation With Simultaneous Integrated Boost to Intraprostatic Lesion

Article ID	Journal	Published Year	Pages	File Type
8237292	International Journal of Radiation OncologyBiologyPhysics	2008	9 Pages	PDF

Abstract

The results of our study have shown that treatment-induced acute toxicity remains low when intensity-modulated radiotherapy to 80 Gy as primary therapy for prostate cancer is used. In addition, a SIB to an IPL did not increase the severity or incidence of acute toxicity.

Keywords

IMRT SIB Intensity-modulated radiotherapy Prostate cancer Acute toxicity Simultaneous integrated boost

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

Intensity-Modulated Radiotherapy as Primary Therapy for Prostate Cancer: Report on Acute Toxicity After Dose Escalation With Simultaneous Integrated Boost to Intraprostatic Lesion

Authors

Valérie M.D., Geert M.D., Ph.D., Bruno R.N., Wilfried M.D., Ph.D., Carlos Ir., Ph.D., Nicolas M.D., Gert M.D., Ph.D.,